Non–Small Cell Lung Cancer Coverage from Every Angle

Luis G. Paz-Ares, MD, PhD, on Managing Immune-Related Adverse Events Associated With Checkpoint Inhibitor Therapy

Posted: Wednesday, October 18, 2017

How do you work with non-oncology specialists who must collaborate with you to manage patients’ complications from checkpoint inhibitors?

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.